Who owns GlaxoSmithKline?
- CUSIP Number: 37733W105
Tip: Access positions for across all investors
Analyze quarterly positions in GlaxoSmithKline with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of GlaxoSmithKline stock
Who bought or sold GlaxoSmithKline this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Kahn Brothers Group | 1.3M | $54M | -2% | Mar 2024 |
|
| Damian Sousa | 17k | $699k | 100% | Mar 2024 |
|
| Columbia Asset Management | 8.3k | $309k | 0% | Mar 2024 |
|
| Paradigm Asset Management Company | 1.8k | $77k | 0% | Mar 2024 |
|
| Accent Capital Management | 920.00 | $40k | 0% | Mar 2024 |
|
| Park Circle | 800.00 | $34k | 0% | Mar 2024 |
|
| Byrne Asset Management | 56.00 | $2.4k | 0% | Mar 2024 |
|
| Retirement Group | 40.00 | $1.7k | 0% | Mar 2024 |
|
| Huntington National Bank | 1.00 | $40.000000 | 0% | Mar 2024 |
|
Who sold out of GlaxoSmithKline?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Bartlett & Co. | Sep 2023 | 240.00 | $9.0k |